Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Altman

Showing results (701-710 of 965) with videos related to

Pageof 97
Sort By:
British Journal of Cancer|June 8, 2013
The benefits and harms of breast cancer screening: an independent reviewM G Marmot, D G Altman, D A Cameron, et al.
International Journal of Epidemiology|July 5, 2016
Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trialsDavid M Kent, Jason Nelson, Issa J Dahabreh, et al.
Journal of Clinical Epidemiology|October 5, 2019
Reporting of randomized factorial trials was frequently inadequateBrennan C Kahan, Michael Tsui, Vipul Jairath, et al.
Gaceta Sanitaria|April 19, 2008
[The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies]Erik von Elm, Douglas G Altman, Matthias Egger, et al.
Epidemiology (Cambridge, Mass.)|December 1, 2007
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesErik von Elm, Douglas G Altman, Matthias Egger, et al.
BMJ (Clinical Research Ed.)|January 30, 2015
Association between randomised trial evidence and global burden of disease: cross sectional study (Epidemiological Study of Randomized Trials--ESORT)Connor A Emdin, Ayodele Odutayo, Allan J Hsiao, et al.
BMJ (Clinical Research Ed.)|October 20, 2007
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesErik von Elm, Douglas G Altman, Matthias Egger, et al.
The Lancet. Diabetes & Endocrinology|September 27, 2014
Fetal growth and ethnic variation--authors' replyJosé Villar, Douglas G Altman, Cesar G Victora, et al.
Plos Medicine|January 18, 2007
Ghost authorship in industry-initiated randomised trialsPeter C Gøtzsche, Asbjørn Hróbjartsson, Helle Krogh Johansen, et al.
The New England Journal of Medicine|December 14, 2016
Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery GraftsDavid P Taggart, Douglas G Altman, Alastair M Gray, et al.
Pageof 97

Showing results (701-710 of 965) with videos related to

Sort By:
Pageof 97
British Journal of Cancer|June 8, 2013
The benefits and harms of breast cancer screening: an independent reviewM G Marmot, D G Altman, D A Cameron, et al.
International Journal of Epidemiology|July 5, 2016
Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trialsDavid M Kent, Jason Nelson, Issa J Dahabreh, et al.
Journal of Clinical Epidemiology|October 5, 2019
Reporting of randomized factorial trials was frequently inadequateBrennan C Kahan, Michael Tsui, Vipul Jairath, et al.
Gaceta Sanitaria|April 19, 2008
[The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies]Erik von Elm, Douglas G Altman, Matthias Egger, et al.
Epidemiology (Cambridge, Mass.)|December 1, 2007
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesErik von Elm, Douglas G Altman, Matthias Egger, et al.
BMJ (Clinical Research Ed.)|January 30, 2015
Association between randomised trial evidence and global burden of disease: cross sectional study (Epidemiological Study of Randomized Trials--ESORT)Connor A Emdin, Ayodele Odutayo, Allan J Hsiao, et al.
BMJ (Clinical Research Ed.)|October 20, 2007
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesErik von Elm, Douglas G Altman, Matthias Egger, et al.
The Lancet. Diabetes & Endocrinology|September 27, 2014
Fetal growth and ethnic variation--authors' replyJosé Villar, Douglas G Altman, Cesar G Victora, et al.
Plos Medicine|January 18, 2007
Ghost authorship in industry-initiated randomised trialsPeter C Gøtzsche, Asbjørn Hróbjartsson, Helle Krogh Johansen, et al.
The New England Journal of Medicine|December 14, 2016
Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery GraftsDavid P Taggart, Douglas G Altman, Alastair M Gray, et al.
Pageof 97